High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathies

Journal of Clinical Investigation

Volumn 101, Issue 10, 1998, Pages 2119-2128

  Lattanzi, L ^a   Salvatori, G ^a   Coletta, M ^a   Sonnino, C ^a   De Angelis, M G C ^a   Gioglio, L ^a   Murry, C E ^a   Kelly, R ^a   Ferrari, G ^a   Molinaro, M ^a   Crescenzi, M ^a   Mavilio, F ^a   Cossu, G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

B HLH myogenic factors; Cell therapy; Gene transfer; Muscular dystrophy; Myogenesis

Indexed keywords

BETA GALACTOSIDASE; BROXURIDINE; DEXAMETHASONE; MYOD PROTEIN; MYOSIN HEAVY CHAIN; MYOSIN LIGHT CHAIN;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; DNA SYNTHESIS; EXPRESSION VECTOR; FIBROBLAST; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; LONG TERMINAL REPEAT; MITOSIS INHIBITION; MOUSE; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; MYOPATHY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

EID: 0032523966     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1505     Document Type: Article

References (39)